Abdominal pain and Bronchospasm aggravated

Summary:

Bronchospasm aggravated is found among people with Abdominal pain, especially for people who are female, 60+ old.

The study analyzes which people have Bronchospasm aggravated with Abdominal pain. It is created by eHealthMe based on reports of 17 people who have Abdominal pain from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Abdominal pain?

Abdominal pain is found to be associated with 3,217 drugs and 5,756 conditions by eHealthMe. Check the latest studies of Abdominal pain.

What is Bronchospasm aggravated?

Bronchospasm aggravated (spasm of bronchial smooth muscle producing narrowing of the bronchi) is found to be associated with 1,003 drugs and 328 conditions by eHealthMe. Check the latest studies of Bronchospasm aggravated.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

17 people who have Abdominal Pain and Bronchospasm Aggravated are studied.

Would you have Bronchospasm aggravated when you have Abdominal pain?

Gender of people who have Abdominal Pain and experienced Bronchospasm Aggravated *:

female: 81.25 %
male: 18.75 %

Age of people who have Abdominal Pain and experienced Bronchospasm Aggravated *:

Common co-existing conditions for these people *:

Pain: 2 people, 11.76%
Nausea (feeling of having an urge to vomit): 2 people, 11.76%
Computerised Tomogram Abdomen: 2 people, 11.76%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 5.88%
Diarrhea: 1 person, 5.88%
Back Pain: 1 person, 5.88%
Cardiac Disorder: 1 person, 5.88%
Cardiac Failure Congestive: 1 person, 5.88%
Chest Pain: 1 person, 5.88%
Cholangitis Sclerosing (infection and obstruction of bile duct): 1 person, 5.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Dyspnea (difficult or laboured breathing): 9 people, 52.94%
Itching: 6 people, 35.29%
Skin Reaction: 5 people, 29.41%
Hypotension (abnormally low blood pressure): 5 people, 29.41%
Urticaria (rash of round, red welts on the skin that itch intensely): 4 people, 23.53%
Nausea And Vomiting: 3 people, 17.65%
Face Oedema (swelling of face): 2 people, 11.76%
Laryngeal Oedema (swelling of larynx): 2 people, 11.76%
Chest Pain: 2 people, 11.76%
Skin Discoloration - Bluish (bluish colour of skin): 2 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Bronchospasm aggravated?

- Check whether Bronchospasm aggravated is associated with a drug or a condition

Related publications that referenced our studies

Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Bronchospasm aggravated and Abdominal pain, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.